Table II.
The total number of inflammatory cells and percentage of eosinophil cells of patients were lower with higher percentages of monocyte, lymphocyte, and neutrophil cells in the anti GER group after treatment.
| Cell percentage (%) | |||||
|---|---|---|---|---|---|
| Group | Total inflammatory cells (10–8) | Lymphocyte | Neutrophil | Eosinophil | Monocyte |
| Routine treatment group | |||||
| Before treatment | 4.64±0.36 | 3.91±0.24 | 20.25±1.15 | 8.89±0.46 | 49.12±2.97 |
| 6 months after treatment | 2.85±0.15a | 5.76±0.46a | 28.34±1.61a | 6.74±0.51a | 56.75±3.30a |
| Anti GER group | |||||
| Before treatment | 4.53±0.37 | 3.82±0.29 | 20.48±2.02 | 8.56±0.54 | 50.13±3.18 |
| 6 months after treatment | 2.41±0.19a,b | 7.49±0.63a,b | 36.11±2.27a,b | 4.21±0.32a,b | 65.33±4.82a,b |
a
P<0.05 compared with patients before treatment.
b
Compared with the routine group.